Audio

30 years of changes in cervical cancer screening. What's in store?


 


One of the greatest successes in medicine is the dramatic decrease in US deaths from cervical cancer that followed the implementation of clinical protocols for cervical cancer screening and treatment.

Dr. J. Thomas Cox has made many contributions to sustaining and advancing cervical cancer screening and treatment practice by developing advanced clinical protocols for managing cervix abnormalities, leading efforts to integrate HPV testing into general screening protocols and encouraging the use of the HPV vaccine to reduce disease burden. At OBG Management, we are deeply indebted to Dr. Cox for providing wise guidance to our readers over many years. His insights and advice have helped to improve women’s health throughout the world.

— Robert L. Barbieri, MD, Editor in Chief

We wish Dr. Cox the best as he retires as Contributing Editor.

Recommended Reading

Risk of anal cancer is high in HIV-infected people
MDedge ObGyn
ACOG calls for routine sexual and reproductive coercion screening
MDedge ObGyn
PCOS panel calls for classification, name changes
MDedge ObGyn
First OTC drug approved for overactive bladder
MDedge ObGyn
Supplement boosts hair growth in women
MDedge ObGyn
Bevacizumab plus chemo extends survival in metastatic cervical cancer
MDedge ObGyn
Breast-conserving therapy improved survival over mastectomy
MDedge ObGyn
FDA approves novel oral estrogen for postmenopausal dyspareunia
MDedge ObGyn
Previous abortion no longer a risk factor for preterm birth
MDedge ObGyn
Trial of labor after C-section uncommon, but often successful
MDedge ObGyn